Benzinga

Benzinga

Benzinga

miércoles, agosto 26

Healthpeak Properties Inc

DOCNYSE
Trade with Public
Trade with Public
$21.68
0.020.09%
Últ. Act.: Aug 26, 9:25 AM
Panorámica generalNoticiasPrevisión de beneficiosPrecios objetivoFinanzasSentimientoPropiedadDividendosCompararOpcionesInforme de acciones

Healthpeak Properties Analyst Price Targets

Wall Street analyst price targets and consensus rating for Healthpeak Properties (DOC).

Price Target Range — 12 Quarters

Analyst Consensus — 19 Analysts

8Buy
11Hold
Consensus RatingOutperform# Analysts19Avg. Consensus PT$21Upside to Avg. PT-2.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 13, 2026BairdAmanda SweitzerPT RaiseOutperform$21→$24
Aug 11, 2026CitigroupNick JosephPT RaiseNeutral$20→$22
More with Benzinga EdgeGet Access

Analyst Ratings News

Wall Street's Most Accurate Analysts Give Their Take On 3 Real Estate Stocks Delivering High-Dividend Yields

In uncertain markets, investors turn to dividend-yielding stocks. Benzinga provides latest analyst ratings & news for high-yielding stocks.
Avi Kapoor

PRO
Baird Maintains Outperform on Healthpeak Properties, Raises Price Target to $24

Baird analyst Amanda Sweitzer maintains Healthpeak Properties (NYSE:DOC) with a Outperform and raises the price target from $21 to $24.
Benzinga Newsdesk

PRO
Citigroup Maintains Neutral on Healthpeak Properties, Raises Price Target to $22

Citigroup analyst Nick Joseph maintains Healthpeak Properties (NYSE:DOC) with a Neutral and raises the price target from $20 to $22.
Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Healthpeak Properties, Raises Price Target to $24

RBC Capital analyst Michael Carroll maintains Healthpeak Properties (NYSE:DOC) with a Outperform and raises the price target from $21 to $24.
Benzinga Newsdesk

PRO
Cantor Fitzgerald Maintains Neutral on Healthpeak Properties, Raises Price Target to $23

Cantor Fitzgerald analyst Richard Anderson maintains Healthpeak Properties (NYSE:DOC) with a Neutral and raises the price target from $20 to $23.
Benzinga Newsdesk

PRO
Wells Fargo Maintains Equal-Weight on Healthpeak Properties, Raises Price Target to $22

Wells Fargo analyst John Kilichowski maintains Healthpeak Properties (NYSE:DOC) with a Equal-Weight and raises the price target from $20 to $22.
Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Datos de mercado proporcionados por APIs de Benzinga

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved